Delivery Order SPE2DB22D1106-SPE2DB25FFBG3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,014.39 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a leuprolide acetate-based pharmaceutical product used in hormonal therapies, and this order represents a single delivery transaction under the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,212.04 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Lupron Depot 3.75 mg kits. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,090.63 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with a firm fixed price structure and no set-aside designation. The award was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a hormone treatment used in medical applications, and this delivery order represents a specific...
- The Defense Logistics Agency awarded a delivery order valued at $15,568.81 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, non-set-aside contract with a completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a hormone treatment medication used in medical applications, and this delivery order represents a specific procurement requirement under the...
- The Defense Logistics Agency (DLA) awarded a $17,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with an ultimate completion date of July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,331.98 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. Lupron Depot is a hormone therapy...
- The Defense Logistics Agency Medical Supply Chain awarded a $42,779.28 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with final delivery required by July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lupron Depot 3.75 mg kits, valued at $15,025.58 under a firm fixed-price contract type. The order, which has an ultimate completion date of July 29, 2025, represents a non-set-aside award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $28,548.57 delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month treatment kits on August 4, 2025, with a completion date of August 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication commonly used in military and federal healthcare systems for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,913.40 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single pharmaceutical delivery under AmerisourceBergen's broader federal medical supply portfolio. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBG3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $37,809.82 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This is a firm fixed-price, non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 5, 2025. Lupron Depot is a gonadotropin-releasing hormone agonist used in medical treatment, and this delivery order represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for military and federal healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies. The company's contract portfolio demonstrates consistent capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.8k | 8/4/25 |